Markets

Stock Alert: DexCom Slips 10%

(RTTNews) - Shares of DexCom, Inc. (DXCM) are currently slipping over 10% despite the medical device company's third-quarter results beating Wall Street estimates. U.S. stocks are trading down on Wednesday morning as investors are worried about the economic impact of spike in coronavirus cases lately.

DXCM is currently trading at $340.21, up $40.42 or 10.62%, on the Nasdaq.

Tuesday, DexCom reported third-quarter profit of $72.2 million or $0.73 per share, up from $45.8 million or $0.50 per share last year. Adjusted earnings increased to $0.94 per share from $0.65 per share last year. Analysts polled by Thomson Reuters estimated earnings of $0.64 per share.

Revenues for the quarter grew 26% to $500.9 million from $396.3 million last year. Analysts had a consensus estimate of $476.75 million.

Looking forward, DexCom expects revenues of about $1.90 billion for the full year. Analysts currently estimate revenues of $1.87 billion.

On Monday, DexCom said that Rick Doubleday, the company's executive vice president and chief commercial officer, will retire at the end of 2020.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

DXCM

Latest Markets Videos

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More